Products and Resources Catalog

Full-day training with fully articulated trainer notes.

Karol Kaltenbach, PhD, Emeritus Professor of Pediatrics at Sidney Kimmel Medical College, delivered a didactic presentation on trauma-informed and trauma-specific services in the context of a PPW program. The presentation discussed how this approach and services fit into the context of family-centered treatment and reviewed available resources and training curricula for staff.

Kathryn Icenhower, PhD, CEO of SHIELDS for Families in Compton, CA delivered a didactic presentation on services for younger children (birth to age 5). The presentation covered what comprises a quality early childhood education program, developmental domains, program design, developmental assessment, services strategies, and staffing.

Opioid Use Disorders are a growing concern across the US, particularly its impact on pregnant women and children. In this webinette, Dr. Jones will present information to put this issue and the treatment of women during pregnancy into context, medications available to treat OUDs in pregnant women, including a review of study outcomes, as well as presentation of questions still to be answered.

ATTC Center of Excellence Director, Pat Stilen, and Steering Committee Chair, Lonnetta Albright, delivered a didactic presentation on family-centered care during the first session of PPW Project ECHO. Their presentation summarized the ATTC Center of Excellence’s integrated framework of family-centered recovery and wellness that incorporates perspectives from the PPW, substance use disorder/recovery, and health care fields.

In this paper, the ATTC pre-service education workgroup addresses how such advancements must progress so that health professionals will be equipped to appropriately care for patients who have, or who are at risk of developing, SUD seven generations into the future.

Co-occurring disorders (CODs) occur frequently and can significantly impact mother and child. In this webinette, Dr. Cooke will present information on the significance of CODs and their risk factors; discuss the importance of repeat screening, appropriate referral, and coordinated treatment; and share the safety profiles of the various medications available to treatment CODs and how to take in account the risks to mother and child.

This is a training on Technology-Assisted Care and will improve awareness of and receptivity to using Technology-Assisted Care (TAC) for the treatment of Substance Use Disorders (SUDs).

The purpose of this introductory training is to provide HIV clinicians (including, but not limited to physicians, dentists, nurses, and other allied medical staff, therapists and social workers, and counselors, specialists, and case managers) with a detailed overview of substance use, HIV, and women

3-hour, self-paced course designed to enhance professional knowledge of MAT and build skills related to educating clients about MAT.

September 2016

The purpose of this introductory training is to provide HIV clinicians (including, but not limited to physicians, dentists, nurses, and other allied medical staff, therapists and social workers, and counselors, specialists, and case managers) with a detailed overview of smoking and HIV

Where you live impacts where you access services, develop supportive relationships, work or go to school. Housing is one of the pillars of recovery. And yet, accessing safe, affordable housing in neighborhoods of choice can be challenging for women and families who are experiencing both substance use disorders and poverty.

This presentation describes the challenges and opportunities working with adolescents with substance use disorders, with a focus on continuity of care. Presented by Yifrah Kaminer, M.D.

Summer 2016

This presentation discussed technology-assisted treatment for adolescent substance use. Presented by Alan Budney, PhD.

This presentation discussed trauma-informed approaches to the assessment and treatment of adolescent substance use. Presented by Kay Jankowski, Ph.D.

Conference Agenda

This presentation had three objectives1. Describe and discuss the potential impact of changes in cannabis laws and regulations 2. Describe the limitations of the evidence for cannabis as a therapeutic substance 3. Describe the primary concerns related to adolescents use of cannabis, and how the changing landscape interacts with these issues. Presented by Alan J. Budney, Ph.D.

For women of color and/or women with tribal affiliation, healing approaches from the chronic diseases of addiction and mental health problems are most successful when they include information on historical trauma as well as on cultural practices that contribute to a sense of comfort, well-being, and spirituality.

An educational product designed for all members of a multidisciplinary team in a treatment and recovery services setting for people with substance use disorders. It has four modules with general topics: Competences, Theoretical models, Professional ethics, and Neurobiology. These modules provide basic and essential information on each of the topics and are presented in a video format where images and text are accompanied by a narrative of the content.  

Substance abuse is a primary reason why many families end up in the child welfare system. In this webinar, we will discuss the program design and funding strategies that can enable providers to keep families together by providing Family Centered Treatment.

This white paper is intended to provide a series of recommendations to guide practitioners in achieving more integrated behavioral health services in their respective settings. The paper presents Screening, Brief Intervention, Referral to Treatment (SBIRT) as a guiding clinical framework and identifies organizational change activities that are necessary to fully implement integrated treatment models.

Pregnant women with Opioid Use Disorder present with a host of special maternal care needs. Studies have found that both Methadone and Buprenorphine have helped to reduce illicit drug use behaviors and promote pre-natal care. Research also suggests that medication assisted treatment with opioid agonists may influence positive birth outcomes, however, this medical intervention must be delivered wi